Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2191-2196

  Ross, Howard M ^a   Weber, Lawrence W ^a   Wang, Siqun ^a   Piskun, Gregory ^a   Dyall, Ruben ^a   Song, Ping ^a   Takechi, Yoshizumi ^a   Nikolić Zugić, Janko ^a   Houghton, Alan N ^a   Lewis, Jonathan J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR REJECTION;

ANIMALS; BETA-GALACTOSIDASE; BIOLISTICS; CANCER VACCINES; INJECTIONS, SUBCUTANEOUS; MAST-CELL SARCOMA; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; OVALBUMIN; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 0031418442     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lewis, J. J., and Houghton, A. N. Definition of tumor antigens for vaccine construction. Semin. Cancer Biol., 6: 321-327, 1995.
2. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene gun inoculations. Proc. Natl. Acad. Sci. USA, 90: 11478-11482, 1993.
3. Webster, R. G., Fynan, E. F., Santoro, J. C., and Robinson, H. L. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine, 12: 1495-1498, 1994.
4. Zaroninski, C. C., Fynan, E. F., Selin, L. K., Robinson, H. L., and Welsh, R. M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol., 154: 4010-4017, 1995.
5. Manickan, E., Rouse, J. D. R., Yu, Z., Wire, W. S., and Rouse, B. T. Genetic immunization against herpes simplex virus. J. Immunol., 155: 259-265, 1995.
6. Germain, R. N. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells involved in phagocytosis. J. Exp. Med., 182: 841-851, 1995.
7. Irvine, K. R., Rao, J. B., Rosenberg, S. A., and Restifo, N. P. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol., 756: 238-245, 1996.
8. Klein, T. M., Wolf, E. D., Wu, R., and Sanford, J. C. High-velocity microprojectiles for delivering nucleic acids into living cells. Nature (Lond.), 327: 70-73, 1987.
9. Williams, R. S., Johnston, S. A., Riedy, M., DeVit, M. J., McElliogott, S. G., and Sanford, J. C. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc. Natl. Acad. Sci. USA, 88: 2726-2730, 1991.
10. Fuller, D. H., and Haynes, J. R. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retroviruses, 10: 1433-1441, 1994.
11. Tang, D., DeVit, M., and Johnston, S. A. Genetic immunization is a simple method for eliciting an immune response. Nature (Lond.), 356: 152-154, 1992.
12. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., and Friedman, A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (Washington DC), 259: 1745-1749, 1993.
13. Corr, M., Delphine, J. L., Carson, D. A., and Tighe, H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med., 184: 1555-1560, 1996.
14. Condon, C., Watkins, S. C., Celluzzi, K., Thompson, K., and Falo, L. D. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med., 2: 1122-1128, 1996.
15. Carbone, F. R., and Bevan, M. J. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med., 171: 377-387, 1990.
16. Dyall, R., Vasovic, L. V., Molano, A., and Nikolić-Zugić, J. CD4-independent in vivo priming of murine CTL by optimal MHC class 1-restricted peptides derived from intracellular pathogens. Int. Immunol., 7: 1205-1212, 1995.
17. Moore, M. W., Carbone, F. R., and Bevan, M. J. Introduction of soluble protein into the class 1 pathway of antigen processing and presentation. Cell, 54: 777-780, 1988.
18. Nikolić-Zugić, J., and Carbone, F. R. The effect of mutations in the MHC class 1 peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant. Eur. J. Immunol., 20: 2431-2435, 1990.
19. Hara, I., Takechi, Y., and Houghton, A. N. Implicating a role of for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. J. Exp. Med., 182: 1609-1614, 1995.
20. Bourne, N. S., Stanberry, L. R., Bernstein, D. I., and Lew, D. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis., 173: 800-807, 1996.
21. Lai, W. C., Bennett, M., Johnston, S. A., Barry, M. A., and Pakes, S. P. Protection against Mycoplasma pulmonis infection by genetic vaccination. DNA Cell Biol., 14: 643-651, 1995.
22. Hengge, U. R., Walker, W. L., and Vogelstein, B. Expression of naked DNA in human, pig, and mouse skin. J. Clin. Invest., 97: 2911-2916, 1996.
23. Fynan, E. F., Webster, R. G., Fuller, D. F., Haynes, J. R., Santoro, J. C., and Robinson, H. L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene gun inoculations. Proc. Natl. Acad. Sci. USA, 90: 11478-11482, 1993.
24. Conry, R. M., LoBuglio, A. F., and Curiel, D. T. Polynucleotide-mediated immunization therapy of cancer. Semin. Oncol., 23: 135-147, 1996.
25. Conry, R. M., LoBuglio, A. F., Loechel, F., Sumerel, L. A., Barlow, D. L., Pike, J., and Curiel, D. T. A carcinoembryonic antigen polynucleotide vaccine for human clinical use. Cancer Gene Ther., 2: 33-38, 1996.
26. Conry, R. M., LoBuglio, A. F., Loechel, F., Moore, S. E., Sumerel, L. A., Barlow, D. L., and Curiel, D. T. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther., 2: 59-65, 1996.
27. Klinman, D. M., Yi, A., Beaucage, S. L., Conover, J., and Kreig, A. M. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6. Proc. Natl. Acad. Sci. USA, 7: 2879-2883, 1996.
28. Sato, Y., Roman, M., Tighe, H., Lee, D., Nguyen, M. D., Silverman, G. J., Lotz, M., Carson, D. A., and Raz, E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (Washington DC), 273: 352-354, 1996.